Clinical characteristics of central compartment atopic disease in Southern China. Issue 3 (21st September 2022)

• Record Type: Journal Article
• Authors: Nie, Zhiying; Xu, Zhaofeng; Fan, Yunping; Guo, Yuanyuan; Chen, Chuxin; Liu, Wendong; Li, Yueqi; Lai, Yinyan; Shi, Jianbo; Chen, Fenghong
• Is Part Of: International forum of allergy & rhinology. Volume 13:Issue 3(2023)
• Page Start: 205
• Page End: 215
• Publication Date: 2022-09-21
• Subjects: allergy -- asthma -- central compartment atopic disease -- endotype -- eosinophilic chronic rhinosinusitis; 617.51005
• DOI: 10.1002/alr.23069
• Languages: English
• ISSNs: 2042-6976

Abstract

Abstract: Background: Central compartment atopic disease (CCAD) is a newly reported subset of chronic rhinosinusitis. It was considered associated with inhalant antigen. However, CCAD in Chinese population is not fully studied yet. Design: Prospective cohort study. Objective: This study aimed to describe the clinical manifestations of CCAD and compared the following two subtypes: sinonasal polyps and concomitant polypoid disease in the central compartment (CRSwNP/CC) and CRSwNP not otherwise specified (CRSwNP NOS). Also, we compared the clinical manifestations of atopy CCAD and non‐atopy CCAD. Methods: We consecutively enrolled CRSwNP patients without prior sinus surgery, and assessed the nasal endoscopy and computed tomography of the paranasal sinuses. Allergy was confirmed by skin or serum testing. Eosinophilic CRSwNP (ECRS) was considered as tissue eosinophils to total inflammatory cells >10%. Results: We enrolled a total of 116 patients, including 39 with CCAD, 38 with CRSwNP/CC and 39 with CRSwNP NOS. Atopy was detected in 37.1% of the CCAD group, an incidence showing no significant difference from those in the other two groups (37.1% in the CRSwNP/CC group, 31.0% in the CRSwNP NOS group; p = 0.846). However, the incidence of ECRS in the CCAD group was the highest among the different groups (97.4% in the CCAD group vs. 67.6% in the CRSwNP/CC group vs. 35.1% in the CRSwNP NOS group; p = 0.000). In addition, the incidence of asthma in the CCAD group (33.3%) was significantly higher than that in the CRSwNP NOS group (10.3%), but quite similar to CRSwNP/CC (34.2%). In the subgroup analysis of CCAD, only total serum IgE and sIgE demonstrated significant differences between atopy CCAD and non‐atopy CCAD. Conclusion: CCAD in Southern China may associate with asthma and significant eosinophilia, with a lower incidence of systemic allergy based on skin and serum testing.